跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Cypress - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Cypress
Approved
STANDARD
Cypress
Mylan Laboratories Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
49cd2b2f71e7a701
Company
Mylan Laboratories Ltd.
Type
Standard
Approval Details
Approval Id
49cd2b2f71e7a701
Drug Approval Philippines Name
Cypress
Product Name
Cypress
Registration Number
DR-XY 48110
Brand Name
Cypress
Generic Name
Cyproterone Acetate + Ethinylestradiol
Dosage Form
Tablet
Dosage Strength
2 mg/35 mcg
Manufacturer
Mylan Laboratories Ltd.
Importer
Mylan Philippines, Inc.
Company Detail Path
/organization/mylan-laboratories-ltd
Issuance Date
16 June 2022
Expiry Date
16 June 2027
Pharmacologic Category
Antiandrogen-Estrogen Combination (Hormonal Contraceptive)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
49cd2b2f71e7a701
Type
Standard
Back to Philippines FDA Approvals